Caitong International Asset Management Co., LTD Enanta Pharmaceuticals Inc Transaction History
Caitong International Asset Management Co., LTD
- $102 Billion
- Q4 2024
A detailed history of Caitong International Asset Management Co., LTD transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 152 shares of ENTA stock, worth $1,085. This represents 0.0% of its overall portfolio holdings.
Number of Shares
152
Previous 152
-0.0%
Holding current value
$1,085
Previous $874,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ENTA
# of Institutions
107Shares Held
18.3MCall Options Held
4.8KPut Options Held
4.6K-
Farallon Capital Management LLC San Francisco, CA2.11MShares$15.1 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.98MShares$14.2 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.85MShares$13.2 Million0.0% of portfolio
-
Krensavage Asset Management, LLC New York, NY1.5MShares$10.7 Million8.7% of portfolio
-
Morgan Stanley New York, NY1.22MShares$8.72 Million0.0% of portfolio
About ENANTA PHARMACEUTICALS INC
- Ticker ENTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,724,900
- Market Cap $148M
- Description
- Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...